These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 20920772)

  • 1. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE
    J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial.
    Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M;
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency.
    Varga L; Farkas H
    Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
    Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
    J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
    Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study.
    Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A
    Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.
    Hack CE; Mannesse M; Baboeram A; Oortwijn B; Relan A
    BioDrugs; 2012 Oct; 26(5):303-13. PubMed ID: 22928662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of peripheral attacks in hereditary angioedema patients.
    Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE
    Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema.
    Relan A; Bakhtiari K; van Amersfoort ES; Meijers JC; Hack CE
    BioDrugs; 2012 Feb; 26(1):43-52. PubMed ID: 22171564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
    van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J
    J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human c1 inhibitor (conestat alfa): in the treatment of angioedema attacks in hereditary angioedema.
    Plosker GL
    BioDrugs; 2012 Oct; 26(5):315-23. PubMed ID: 22946752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
    J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW; Bernstein JA; Harper JR; Relan A; Riedl MA
    Allergy Asthma Proc; 2018 Sep; 39(5):359-364. PubMed ID: 29954477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate.
    Bork K; Hardt J
    Am J Med; 2009 Aug; 122(8):780-3. PubMed ID: 19635282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
    Bernstein JA; Relan A; Harper JR; Riedl M
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
    Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME
    J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2).
    Krassilnikova S; Craig ET; Craig TJ
    Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.